Publicação

In silico selection of an ssDNA aptamer against HER2-positive breast cancer cells using computational docking simulation

Detalhes bibliográficos
Autores principais:	Sousa, Diana Andrade
Outros Autores:	Ferreira, Débora; Rodrigues, L. R.
Assunto:	Aptamers SELEX Breast cancer HER 2
Ano:	2017
País:	Portugal
Tipo de documento:	outro
Tipo de acesso:	acesso aberto
Instituição associada:	Universidade do Minho
Idioma:	inglês
Origem:	RepositóriUM - Universidade do Minho

Registos relacionados

In vitro selection of DNA aptamers against staphylococcal enterotoxin A
por: Oliveira, Ricardo
Publicado em: (2024)

In vitro selection of DNA aptamers against human osteosarcoma
por: Tsogtbaatar, Khaliunsarnai
Publicado em: (2022)

Electrochemical aptasensor for human osteopontin detection using a DNA aptamer selected by SELEX
por: Meirinho, S.
Publicado em: (2017)

Aptamers for blocking F18+ enterotoxigenic Escherichia coli
por: Campos, Ana Maria Silva
Publicado em: (2024)

Moving towards personalized medicine - the broad use of aptamers for targeted theranostic
por: Sousa, André P.
Publicado em: (2023)

Aptamers for blocking enterotoxigenic Escherichia coli
por: Barros, Maria Margarida
Publicado em: (2023)

Recent advances in the selection of cancer-specific aptamers for the development of biosensors
por: Sousa, Diana
Publicado em: (2022)

Nucleic Acid Aptamer-Based Biosensors: A Review
por: Sequeira-Antunes, Beatriz
Publicado em: (2023)

Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches
por: Oliveira, Ricardo
Publicado em: (2022)

Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer
por: Fiúza, Manuela
Publicado em: (2009)

Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial
por: Maurer, Christian
Publicado em: (2025)

Production, optimization and efficiency evaluation of CAR-T cells against HER2 positive breast cancer cells
por: Lopes, Inês Alexandra de Matos
Publicado em: (2024)

Therapeutic options in HER2-low breast cancer
por: Cavaco, Patrícia Alexandra Teixeira
Publicado em: (2023)

Voltammetric aptasensors for protein disease biomarkers detection: a review
por: Meirinho, Sofia G.
Publicado em: (2016)

Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer : exploratory analysis from the CLEOPATRA trial
por: Ferreira, Arlindo
Publicado em: (2021)

HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device
por: Lopes, Cláudia
Publicado em: (2021)

Tyrosine kinase inhibitors are promising therapeutic tools for cats with HER2-positive mammary carcinoma
por: Gameiro, Andreia
Publicado em: (2021)

Electrochemical aptasensor for the detection of the key virulence factor YadA of Yersinia enterocolitica
por: Sande, Maria Georgina
Publicado em: (2022)

Application of DNA aptamers to block enterotoxigenic Escherichia coli toxicity in a Galleria mellonella larval model
por: Barros, Maria Margarida
Publicado em: (2024)

Aptamer-based therapy for fighting biofilm-associated infections
por: Sousa, Ana Margarida
Publicado em: (2024)

Improving feline mammary carcinoma treatment through HER2-related immunochemotherapy agents and biomarkers
por: Gameiro, Andreia
Publicado em: (2022)

Proimmunotoxin: a novel design strategy of immunotoxins applied to breast cancer
por: Manuel, Ana Margarida de Abreu
Publicado em: (2018)

Are aptamer-based biosensors the future of the detection of the human gut microbiome? - a systematic review and meta-analysis
por: Moreira, Maria João
Publicado em: (2024)

Unveiling the traits of HER2-low breast cancer: a comparative analysis of IHC1+ vs IHC2+/ISH-negative subgroups – insights from a 3-year cohort study
por: Correia, Jorge
Publicado em: (2025)

Use of trastuzumab in patients with early breast cancer : a multi-institutional study
por: Francisco, Rudolfo Pais Mendes Ferreira
Publicado em: (2016)

Peptide-mediated targeted delivery system towards triple negative breast cancer treatment
por: Ferreira, Débora Carina Gonçalves Abreu
Publicado em: (2021)

Real world data regarding management of positive hormone receptors - HER-2 negative early breast cancer with high risk of relapse, previously to adjuvant Abemaciclib use : a retrospective study in a certified breast unit
por: Cardoso, André Filipe da Silva Lopes
Publicado em: (2023)

Aptasensor for the detection of Moraxella catarrhalis adhesin UspA2
por: Sande, Maria
Publicado em: (2023)

Avaliação dos níveis serológicos de HER-2 : relevância clínica em cadelas com tumores mamários malignos
por: Pereira, Marta Ornelas Dantas
Publicado em: (2015)

HER2-Targeted immunotherapy and combined protocols showed promising antiproliferative effects in feline mammary carcinoma cell-based models
por: Gameiro, Andreia
Publicado em: (2021)

Quantificação do domínio extracelular do oncogene HER-2 no soro de gatas com carcinomas mamários : otimização e relevância clínica
por: Coelho, Nuno Filipe Ramos
Publicado em: (2013)

c-myc, not her-2/ neu, can predict the prognosis of breast cancer patients : how novel, how accurate, and how significant?
por: Schmitt, Fernando C.
Publicado em: (2003)

Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cells
por: Souto, Eliana B.
Publicado em: (2019)

HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors
por: Martinho, Olga
Publicado em: (2017)

Introduction to Away from Her
por: Casal, Maria Teresa Correia, 1964-
Publicado em: (2011)

O LDL-colesterol na agressividade do cancro da mama HER2+ e na sensibilidade ao Trastuzumab
por: Oliveira, Emanuel Estevez de
Publicado em: (2021)

Consenso Técnico para a determinação do status da proteína HER2 por imunocitoquímica em carcinoma da mama
por: Maia-Matos, Mário
Publicado em: (2012)

Clinical and molecular characterization of feline mammary carcinomas overexpressing HER2 proto-oncogene (FMC-HER2+) : new strategies for effective diagnostic and cancer therapy
por: Silva, Maria João da Costa Soares da
Publicado em: (2016)

Classificação automática da expressão HER2em imagens de hibridização in situ de tecido mamário
por: Mendes, João Manuel Duarte
Publicado em: (2018)

The impact of cold ischaemia time on the immunolabelling of oestrogen receptors, progesterone receptors, and HER2: a systematic review
por: Noje, Madalina
Publicado em: (2025)